Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Kedudukan dalam Saham #11764
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Harga Saham
$17.81
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$661.63M
Perubahan (1 hari)
0.30%
Perubahan (1 tahun)
23.70%
Negara
US
Perdagangan Crescent Biopharma, Inc. (CBIO)

Kategori

Sejarah hasil dividen untuk Crescent Biopharma, Inc. (CBIO)
Hasil dividen (TTM) bagi Crescent Biopharma, Inc. (simbol saham: CBIO) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Crescent Biopharma, Inc. (CBIO) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH